HealthQuill Colorectal cancer
fizer Inc.’s combination drug to treat a type of metastatic colorectal cancer has been approved by the US drug regulator, according to a company statement.
Drugs Medical Pharma

Pfizer’s drug to treat metastatic colorectal cancer gets US approval

fizer Inc.’s combination drug to treat a type of metastatic colorectal cancer has been approved by the US drug regulator, according to a.

Read More
Merck & Co., announced its trial drug along with a combination of the company’s Keytruda therapy failed to meet the main goal of overall survival in patients previously treated for a type of metastatic colorectal cancer. 
Drugs Health Pharma

Merck’s trial drug combination for colorectal cancer fails main goal

Merck & Co., announced its trial drug along with a combination of the company’s Keytruda therapy failed to meet the main goal of.

Read More
Seventeen types of cancer are common in US millennials and the incidence rate for some forms is two to three times higher in people born in 1990 than in 1995, a study reveals.
Drugs Health Pharma

GenX faces a higher risk of 17 cancer types than older generation

Seventeen types of cancer are common in US millennials and the incidence rate for some forms is two to three times higher in.

Read More
The US Food and Drug Administration has greenlighted Bristol Myers Squibb’s combination therapy to treat metastatic colorectal cancer in patients with a mutated gene.
Drugs Health Pharma

FDA gives nod to Bristol Myer’s colorectal cancer therapy

The US Food and Drug Administration has greenlighted Bristol Myers Squibb’s combination therapy to treat metastatic colorectal cancer in patients with a mutated.

Read More
More than 35 million people may have cancer in 2050 — an increase of 77% from 20 million new cases in 2022, according to a WHO report.
Drugs Health Pharma

Cancer cases set to rise by 77% to 35 million in 2050: WHO global survey

More than 35 million people may have cancer in 2050 — an increase of 77% from 20 million new cases in 2022, according.

Read More
Type 2 diabetic patients, especially African Americans and people with low income, are at a 47% increased risk of developing colorectal cancer (CRC), researchers said.
Drugs Health Pharma

Type 2 diabetics 47% more prone to develop colorectal cancer: Researchers

HQ Team November 15, 2023: Type 2 diabetic patients, especially African Americans and people with low income, are at a 47% increased risk.

Read More
Bristol Myers Squibb, one of the world’s largest pharmaceutical companies, will acquire Mirati Therapeutics for $5.8 billion through a combination of cash and debt to broaden its cancer portfolio.
Drugs Health Pharma

Bristol Myers acquires Mirati Therapeutics for $5.8 billion

HQ Team October 9, 2023: Bristol Myers Squibb, one of the world’s largest pharmaceutical companies, will acquire Mirati Therapeutics for $5.8 billion through.

Read More
Researchers at the Harvard Medical School and Taiwan’s National Change Kung University have invented a new artificial intelligence tool to accurately predict survival rates during and after colorectal cancer.
Drugs Medical Pharma

Free AI tools can predict how long a patient can survive colorectal cancer

HQ Team April 17, 2023: Researchers at the Harvard Medical School and Taiwan’s National Change Kung University have invented a new artificial intelligence.

Read More